about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useDirect-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine PhysiciansIs solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentReversal of target-specific oral anticoagulantsEvidence and triggers for the transfusion of blood and blood productsThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionDeclining blood collection and utilization in the United States.Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals.Transfusion associated circulatory overloadPathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Current treatment for venom-induced consumption coagulopathy resulting from snakebiteTransfusion transmitted diseases in perioperative and intensive care settings.The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage.Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.Cryoprecipitate therapy.Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversalRandomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapySafety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical TrialsReporting adverse transfusion reactions: A retrospective study from tertiary care hospital from New Delhi, India.An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis.Use of plasma in the management of central nervous system bleeding: evidence-based consensus recommendations.Evaluation of a fixed, weight-based dose of 3-factor prothrombin complex concentrate without adjunctive plasma following warfarin-associated intracranial hemorrhage.Improving appropriateness of blood utilization through prospective review of requests for blood products: the role of pathology residents as consultants.The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based.Reversal of anticoagulant effects in patients with intracerebral hemorrhage.Controversies in the use of fresh frozen plasma in critically ill small animal patients.Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: A propensity matching analysis.Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs.Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.Cardiopulmonary Bypass in a Patient with Factor XII Deficiency.Plasma Transfusion in Critically Ill Children. A Magical Mystery Tour?Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.Preparation of red blood cell concentrates and plasma units from whole blood held overnight using a hollow-fibre separation system.Effect of fresh frozen plasma on the in vitro activation of U937 monocytes: a potential role for the age of blood donors and their underlying cytokine profile.Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment.A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18).The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.Transfusion management of factor V deficiency: three case reports and review of the literature.Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?
P2860
Q26741073-A62CBB55-5457-4B1F-8318-41494D9AB591Q26746917-B4755895-1F46-4C4B-9EC5-7C8006370DF5Q26748355-18D82B33-6907-4BF2-9189-1348FE6D6DB2Q27003866-CD91A3D4-3C89-4B77-ACDB-BE118B26264DQ27008573-0F6568A8-66E1-437D-8FA1-AA25612B59BEQ27339343-AA053327-EBFA-4965-9DE8-A88548757A12Q30152037-068A1EB9-FF25-4459-93EB-6082F8E321F3Q30654191-EB8D64B8-DFB3-46AE-8365-08640D70A348Q33809348-47B3ECBE-40A0-49A5-946D-50CC85995C47Q33841435-5EEA3A1D-93BB-495A-AB9F-53AA8E476A85Q34394906-2B62AE4C-5725-45EF-968A-78E299EC2C9AQ34659778-62611A95-53F4-423B-912B-117296C5064EQ35973813-92EFA672-967E-4F3E-AAB4-B49CE50D9883Q36113225-375E76E0-913F-4E62-806F-CF5E6EDF8A04Q36232259-45C0FA5C-5D16-49E3-B22F-53FA483E5670Q36584522-0C794433-952A-461A-804B-BDC28342C8ECQ37019701-A9CE4FEE-A48A-4A1B-A498-C8965F24ED0CQ37352419-6395A0FB-F451-4D1B-9DED-9C592BCCCE75Q37692665-32813C39-35E9-4174-B27B-D064A2C5AB1CQ38107909-9DB851B6-CD35-42C7-AD26-DB6CCBE2C720Q38171401-847B62F9-31B6-4129-A919-5CD02BD459DDQ38208187-36AA8688-B6E0-459F-A410-DD8CDA106C03Q38232683-0094BB24-3872-4604-B2B2-202A5F78060DQ38234399-D4E9F647-4902-4CBF-A597-847B14BBA607Q38269290-453F6083-7D5F-4B2B-890E-99A63B40A414Q38325203-C4A9EEB5-10D4-493C-A04F-4BE3474F2175Q39421853-3E82B0BE-D20E-4539-ABB7-2FB27F4A27D0Q40098378-6CDD7AB0-8B21-4B91-B7DE-520DEF986A15Q40150149-24D252D7-E0D1-4708-8AF2-A942B39DC8A9Q42678381-E201C2CC-75DB-4A58-8EBC-A5A2A0C825BCQ43202830-D75ED8ED-4224-424E-AD0C-608F10461533Q46347983-19D03456-C253-4EFD-BCB2-A4A2C00C7147Q47562442-07C26159-CC93-422D-946C-2B396BA11547Q47570576-361E92C3-6E33-4D82-A3B1-DF750226D783Q48363249-34ACE680-2EF0-4CA0-BBE7-642EE89C891CQ48669003-A96AD874-B27C-4645-B23E-DDA2702E8009Q48964762-57645483-A6E9-4816-92CF-87A98A1AA4DCQ50200375-6A564560-3045-4749-B218-4AC448E91467Q50865356-EDE9F01D-5E62-4248-BF50-11F7FBC37151Q51332285-0AA9C484-A150-4BF8-9CEB-A825A44AF930
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Adverse effects of plasma transfusion
@ast
Adverse effects of plasma transfusion
@en
type
label
Adverse effects of plasma transfusion
@ast
Adverse effects of plasma transfusion
@en
prefLabel
Adverse effects of plasma transfusion
@ast
Adverse effects of plasma transfusion
@en
P2860
P1433
P1476
Adverse effects of plasma transfusion
@en
P2093
Girish N Vyas
Suchitra Pandey
P2860
P304
P356
10.1111/J.1537-2995.2012.03663.X
P478
52 Suppl 1
P577
2012-05-01T00:00:00Z